VivoSim Labs (VIVS) Long-Term Debt Issuances (2011)
VivoSim Labs (VIVS) posted quarterly Long-Term Debt Issuances of $9500.0 for Q4 2011, up 195.0% quarter-over-quarter from -$10000.0 in Q2 2011.
VivoSim Labs (VIVS) Long-Term Debt Issuances (2011) Analysis & Trends
VivoSim Labs' Long-Term Debt Issuances history runs 1 years deep, the most recent figure standing at $9500.0 for Q4 2011.
- In Q4 2011, Long-Term Debt Issuances changed N/A year-over-year to $9500.0; the TTM figure through Dec 2011 stood at $159500.0 (changed N/A YoY), while the FY2011 annual figure was $250000.0, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2011 stood at $9500.0, up from -$10000.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $160000.0 in Q1 2011, with the low at -$10000.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 9,500.00 |
| Dec 31, 2011 | 9,500.00 |
| Jun 30, 2011 | -10,000.00 |
| Jun 30, 2011 | -10,000.00 |
| Mar 31, 2011 | 160,000.00 |
| Mar 31, 2011 | 160,000.00 |